Pharmaceutical companies must contend with challenges from supply chain lapses (theft, diversion, S.O.P. deviations, product recalls, reverse logistics etc.) counterfeiting and stringent regulations. These challenges get compounded when dealing across the states and country business operations, besides that not only impact tangible profits but also the intangible brand credibility. In this context, there is also a credible increase in public awareness about the genuineness of medicine (in particular medicine that require cold chain) and their predictability of clinical outcomes. Providing visibility and full traceability becomes a paramount importance to both the Industry and the Govt. – A fool proof solution not only brings transparency in the system, but can also be a key differentiator, and undoubtedly can create immense opportunities for a competitive advantage.

Contact Us
Terms of Service
Privacy Statement

Facebook

Twitter

Youtube

Healthcare Trends

Do Retail Pharmacies Really Care about Patients?

The chemist shop—jammed between a chai stall and a...

Indian Oncology: An Unasked Question, the Challenges Ahead

A Brief History of Scale and an Unasked Question In...

Are Quick Remedies Keeping Patients Away from Doctors?

The recent Mint Lounge analysis captured a striking consumer...

From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey

Abstract The U.S. Food and Drug Administration (FDA) evolved from...

Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader

In a landmark decision for India’s biotechnology sector, Kiran...

Marketing

Do Retail Pharmacies Really Care about Patients?

The chemist shop—jammed between a chai stall and a...

Indian Oncology: An Unasked Question, the Challenges Ahead

A Brief History of Scale and an Unasked Question In...

Are Quick Remedies Keeping Patients Away from Doctors?

The recent Mint Lounge analysis captured a striking consumer...

From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey

Abstract The U.S. Food and Drug Administration (FDA) evolved from...

Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader

In a landmark decision for India’s biotechnology sector, Kiran...

Policies/Sales

Do Retail Pharmacies Really Care about Patients?

The chemist shop—jammed between a chai stall and a...

Indian Oncology: An Unasked Question, the Challenges Ahead

A Brief History of Scale and an Unasked Question In...

Are Quick Remedies Keeping Patients Away from Doctors?

The recent Mint Lounge analysis captured a striking consumer...

From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey

Abstract The U.S. Food and Drug Administration (FDA) evolved from...

Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader

In a landmark decision for India’s biotechnology sector, Kiran...

Strategy

Do Retail Pharmacies Really Care about Patients?

The chemist shop—jammed between a chai stall and a...

Indian Oncology: An Unasked Question, the Challenges Ahead

A Brief History of Scale and an Unasked Question In...

Are Quick Remedies Keeping Patients Away from Doctors?

The recent Mint Lounge analysis captured a striking consumer...

From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey

Abstract The U.S. Food and Drug Administration (FDA) evolved from...

Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader

In a landmark decision for India’s biotechnology sector, Kiran...

Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
- FFE+CEO RT
- BrandStorm
Solutions & Pricing
Partner

Hot topics

A Social Experiment

Articles by K. Hariram, Vivek Hattangadi, Hanno Wolfram, RB Balakrishna and Rajiv Jayaraman

Are Indian Pharma Business Leaders Adopting Digital Transformation?

We will need to find a way to bring together the capabilities of the Medical Rep, the changed scenario of the visit and the ways we can reach doctors into one single strategy rather than looking at the physical and the digital parts separately. Our medical reps will continue to be the core of our promotion, and our digital strategy will need to empower them to not only do a better call but also support their efforts by building processes that will help them beyond the few minutes that they spend in the Clinic. Marketing budgets will have to move away from conventional investments and also think beyond hardware to increase digital engagement.

Elephant in the Doctor’s Clinic: Indian Pharma Medical Rep

For decades, the Medical Representative has been the backbone...

IMS Health Market Reflection Report for September 2016

The Indian Pharmaceutical Market (IPM) was valued at Rs. 10,278 crs in the month of September 2016 clocking a strong 10% growth over same period last year (SPLY). On a MAT September basis, the industry was valued at Rs. 111,022 crores and reflected a 13% growth with volumes contributing around 40% of this growth and New Introductions playing an important role with around 38% contribution to the overall growth.

Legal Scrutiny

The October 2016 Issue of MedicinMan features articles by K. Hariram, Vivek Hattangadi, Anup Soans and has a special focus on ethics and morals in the healthcare profession. Other topics covered include new product launches, the role of emotions in pharma sales and sales coaching.